Orally Administered CF101 Data / Phase 2 Clinical Trial

[RDAC]

http://www.ncbi.nlm.nih.gov/pubmed/2...t=AbstractPlus

CONCLUSIONS: CF101, given orally, induced a statistically significant improvement in the corneal staining and an improvement in the BUT and TM in patients with moderate to severe dry eye syndrome.

[wetEyes]

Thank you for posting this.

Man, there's so much going on with dry eye / MGD at the moment, it's incredible.